Cargando…

Evidence of platelet activation in multiple sclerosis

OBJECTIVE: A fatality in one multiple sclerosis (MS) patient due to acute idiopathic thrombocytopenic purpura (ITP) and a near fatality in another stimulated our interest in platelet function abnormalities in MS. Previously, we presented evidence of platelet activation in a small cohort of treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheremata, William A, Jy, Wenche, Horstman, Lawrence L, Ahn, Yeon S, Alexander, J Steven, Minagar, Alireza
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2474601/ https://www.ncbi.nlm.nih.gov/pubmed/18588683 http://dx.doi.org/10.1186/1742-2094-5-27

Ejemplares similares

Interferon-β1a reduces plasma CD31+ endothelial microparticles (CD31+EMP) in multiple sclerosis
por: Sheremata, William A, et al.
Publicado: (2006)

Role of platelets in neuroinflammation: a wide-angle perspective
por: Horstman, Lawrence L, et al.
Publicado: (2010)

Clinical and neuroimaging correlates of antiphospholipid antibodies in multiple sclerosis: a preliminary study
por: Bidot, Carlos J, et al.
Publicado: (2007)

Microglia and Astrocytes in Neuro-Aids, Alzheimers Disease, and Multiple Sclerosis
por: Minagar, Alireza, et al.
Publicado: (2001)

Antiphospholipid antibodies: Paradigm in transition
por: Horstman, Lawrence L, et al.
Publicado: (2009)

Current and Future Therapies for Multiple Sclerosis
por: Minagar, Alireza
Publicado: (2013)

Soluble HLA measurement in saliva and cerebrospinal fluid in Caucasian patients with multiple sclerosis: a preliminary study
por: Adamashvili, Irena, et al.
Publicado: (2005)

Inflammation induces neuro-lymphatic protein expression in multiple sclerosis brain neurovasculature
por: Chaitanya, Ganta Vijay, et al.
Publicado: (2013)

Bioinformatics Analyses Determined the Distinct CNS and Peripheral Surrogate Biomarker Candidates Between Two Mouse Models for Progressive Multiple Sclerosis
por: Omura, Seiichi, et al.
Publicado: (2019)

Dalfampridine: Review of its Efficacy in Improving Gait in Patients with Multiple Sclerosis
por: Sahraian, M.A., et al.
Publicado: (2011)

Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis
por: Saluk-Bijak, Joanna, et al.
Publicado: (2019)

Saliva soluble HLA as a potential marker of response to interferon-β1a in multiple sclerosis: A preliminary study
por: Minagar, Alireza, et al.
Publicado: (2007)

Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report
por: Gaitour, Emil, et al.
Publicado: (2012)

Cutaneous and pulmonary sarcoidosis following treatment of multiple sclerosis with interferon-β-1b: a case report
por: Sahraian, Mohammad Ali, et al.
Publicado: (2013)

Blood platelet RNA enables the detection of multiple sclerosis
por: Sol, Nik, et al.
Publicado: (2020)

Evaluation of the risk of cervical cancer in patients with Multiple Sclerosis treated with cytotoxic agents: A cohort study
por: Doosti, Rozita, et al.
Publicado: (2018)

Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis
por: Mehdi-Alamdarlou, Sanaz, et al.
Publicado: (2023)

‘No evidence of disease activity’ – is it an appropriate surrogate in multiple sclerosis?
por: Hegen, H., et al.
Publicado: (2018)

The Multiple Sclerosis Prodrome: Evidence to Action
por: Tremlett, Helen, et al.
Publicado: (2022)

Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients
por: Farrokhi, Mehrdad, et al.
Publicado: (2015)

Neuronal and astrocytic interactions modulate brain endothelial properties during metabolic stresses of in vitro cerebral ischemia
por: Chaitanya, Ganta Vijay, et al.
Publicado: (2014)

Employment among Patients with Multiple Sclerosis-A Population Study
por: Bøe Lunde, Hanne Marie, et al.
Publicado: (2014)

Troglitazone, a PPAR-γ activator prevents endothelial cell adhesion molecule expression and lymphocyte adhesion mediated by TNF-α
por: Sasaki, Makoto, et al.
Publicado: (2005)

Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients
por: Morel, Agnieszka, et al.
Publicado: (2017)

Saffold cardiovirus and multiple sclerosis: no evidence for an association
por: Galama, Jochem M D, et al.
Publicado: (2014)

No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019)

Disease Activity and Progression in Multiple Sclerosis: New Evidences and Future Perspectives
por: Del Negro, Ilaria, et al.
Publicado: (2022)

Platelet Inhibition by Low-Dose Acetylsalicylic Acid Reduces Neuroinflammation in an Animal Model of Multiple Sclerosis
por: Vogelsang, Anna, et al.
Publicado: (2021)

Acupuncture and Multiple Sclerosis: A Review of the Evidence
por: Karpatkin, H. I., et al.
Publicado: (2014)

The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y(12) Pathway in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Pharmacokinetics of Human Red Blood Cell Microparticles Prepared Using High-Pressure Extrusion Method
por: Jy, Wenche, et al.
Publicado: (2018)

“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2017)

Brain Endothelial Cells Release Apical and Basolateral Microparticles in Response to Inflammatory Cytokine Stimulation: Relevance to Neuroinflammatory Stress?
por: Yun, J. Winny, et al.
Publicado: (2019)

Evidence for the Role of B Cells and Immunoglobulins in the Pathogenesis of Multiple Sclerosis
por: Wootla, Bharath, et al.
Publicado: (2011)

Viral Infection and Multiple Sclerosis
por: Williams, Elizabeth L., et al.
Publicado: (2007)

Platelet-derived growth factor predicts prolonged relapse-free period in multiple sclerosis
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Albumin and multiple sclerosis
por: LeVine, Steven M.
Publicado: (2016)

Infection and Multiple Sclerosis
por: Soldan, Samantha S., et al.
Publicado: (2004)

Phenotype analysis and clinical management in a large family with a novel truncating mutation in RASGRP2, the CalDAG‐GEFI encoding gene
por: Desai, Amrita, et al.
Publicado: (2017)

Month of Birth and the Incidence of Multiple Sclerosis in Southern Iran
por: Nikseresht, Alireza, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dvue10c1dn7t0l9d5qaitm8p39